Literature DB >> 11814622

Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected].

Sulaiman Sheriff1, Asbah F Qureshy, William T Chance, John W Kasckow, Ambikaipakan Balasubramaniam.   

Abstract

The role of Ca(2+)/cAMP-dependent signal transduction and transcription factor CREB in mediating NPY- Y(1) receptor function was investigated in SK-N-MC cells. The Y(1) receptor agonist, [Leu(31),Pro(34)]-NPY, inhibited forskolin-stimulated cAMP production which was insensitive to thapsigargin or the CaM kinase II inhibitor, KN-93. Although activation of the Y(1) receptor leads to an increase in CREB phosphorylation, [Leu(31),Pro(34)]-NPY inhibited CREB phosphorylation in KN-93-treated cells. SK-N-MC cells were also transfected with PathDetect cis-CRE and trans-CREB/trans-cFos reporter genes to monitor the role of Ca(2+)/cAMP signals, triggered by Y(1) receptor, on reporter gene activity. Treatment of the cis-CRE-luciferase expression vector-transfected cells with [Leu(31),Pro(34)]-NPY increased reporter gene activity by 2 fold through a KN-93 sensitive pathway. In contrast, the peptide inhibited forskolin-stimulated luciferase activity. Consistently, [Leu(31),Pro(34)]-NPY induced trans-CREB mediated luciferase activity through a CaM kinase dependent pathway, and inhibited forskolin-stimulated luciferase gene expression. However, no effect of the peptide was observed on trans-cFos- mediated luciferase activity. These findings suggest that the NPY Y(1) receptor induces the expression of CRE containing target genes through the CaM kinase-CREB pathway, and inhibits CRE containing genes when cellular cAMP levels are elevated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814622     DOI: 10.1016/s0196-9781(01)00583-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats.

Authors:  Huaibo Zhang; Amul J Sakharkar; Guangbin Shi; Rajesh Ugale; Anand Prakash; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2009-12-18       Impact factor: 3.455

2.  Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy.

Authors:  Congyi Lu; Jason U Tilan; Lindsay Everhart; Magdalena Czarnecka; Steven J Soldin; Damodara R Mendu; Dima Jeha; Jailan Hanafy; Christina K Lee; Junfeng Sun; Ewa Izycka-Swieszewska; Jeffrey A Toretsky; Joanna Kitlinska
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

Review 3.  Neuroscience of alcoholism: molecular and cellular mechanisms.

Authors:  Sachin Moonat; Bela G Starkman; Amul Sakharkar; Subhash C Pandey
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

4.  Micellar nanomedicine of human neuropeptide Y.

Authors:  Antonina Kuzmis; Sok Bee Lim; Esha Desai; Eunjung Jeon; Bao-Shiang Lee; Israel Rubinstein; Hayat Onyüksel
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

5.  An Indirect Action Contributes to C-Fos Induction in Paraventricular Hypothalamic Nucleus by Neuropeptide Y.

Authors:  Shengjie Fan; Janani Dakshinamoorthy; Eun Ran Kim; Yong Xu; Cheng Huang; Qingchun Tong
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

Review 6.  The Role of Neuropeptide Y in the Nucleus Accumbens.

Authors:  Masaki Tanaka; Shunji Yamada; Yoshihisa Watanabe
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.